RCM
CHAQ.U

Radcliffe Capital Management’s Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one CHAQ.U Stock Holding History

Radcliffe Capital Management’s Portfolio CHAQ.U Stock Details CHAQ.U Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-125,000
Closed -$1.31M – 264
2020
Q2 		$1.31M Buy
+125,000
New +$1.25M 0.18% 85

Other funds holding CHAQ.U

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Radcliffe Capital Management's CHAQ.U Position: Q3 2020 in Review

Radcliffe Capital Management sold out of Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one (CHAQ.U) in Q3 2020, closing a stake of 125,000 shares — an estimated $1.31M sold.

Radcliffe Capital Management first reported a position in CHAQ.U in Q2 2020 and held it in 1 quarter. The position peaked at $1.31M in Q2 2020. 15 funds tracked by Wall St. Rank hold CHAQ.U as of Q3 2020.

  • Radcliffe Capital Management reported no remaining Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one position as of Q3 2020 after selling out during the quarter.
  • Radcliffe Capital Management sold 125,000 Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one shares in Q3 2020, an estimated $1.31M.
  • Radcliffe Capital Management first reported a position in Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one in Q2 2020 and held it in 1 quarter.
  • Radcliffe Capital Management's Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one position peaked at $1.31M in Q2 2020.
  • 15 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one as of Q3 2020.

Based on Radcliffe Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.